These data indicate the independence of TMB and CD8+TIL density and the involvement of ARID1A alterations in antitumor immune responses in patients with cervical cancers treated with radiotherapy, warranting further mechanistic research and prospective validation. The gene discussed is CD8A; the disease is cervical carcinoma.